id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-345480-w5zxzpj7	SHI, C.	Clinical observations of low molecular weight heparin in relieving inflammation in COVID-19 patients: A retrospective cohort study	2020-04-01		.txt	text/plain	3747	214	52	D-dimer, C-reactive protein (CRP), peripheral blood lymphocyte percentage, interleukin-6, and other indices in 42 patients with novel coronavirus pneumonia were retrospectively analyzed to compare and evaluate the progress of patients before and after LMWH treatment. Compared to the control group, patients in the heparin group had a higher percentage of lymphocytes after treatment and lower levels of interleukin-6; these differences were statistically significant. This study aims to review and analyze the treatment course of patients with COVID-19 to investigate the anti-inflammatory effects of heparin and delay disease progression to provide guidance for subsequent clinical practice. In addition, the changes in lymphocyte percentages in patients in the heparin group before and after LMWH treatment were significantly different to those in the control group. As shown in Figure 2O , there were no significant differences in CRP levels between the two groups of patients before and after LMWH treatment, and both were significantly lower compared to before treatment.	./cache/cord-345480-w5zxzpj7.txt	./txt/cord-345480-w5zxzpj7.txt